Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan van Meerbeeck

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The Lancet. Respiratory Medicine|May 20, 2019
Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trialGiorgio V Scagliotti, Rabab Gaafar, Anna K Nowak, et al.
Eclinicalmedicine|April 9, 2025
Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation studyLuigi Lim, Abigirl Machingura, Mekdes Taye, et al.
Cell Reports. Medicine|November 9, 2023
Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort BXiuning Le, Luis G Paz-Ares, Jan Van Meerbeeck, et al.
Cancers|February 5, 2021
Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised MedicineDenis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
The European Respiratory Journal|October 6, 2023
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancerEmma L O'Dowd, Ilona Tietzova, Emily Bartlett, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 7, 2023
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancerEmma L O'Dowd, Ilona Tietzova, Emily Bartlett, et al.
The New England Journal of Medicine|May 30, 2020
Tepotinib in Non-Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping MutationsPaul K Paik, Enriqueta Felip, Remi Veillon, et al.
The Cochrane Database of Systematic Reviews|March 3, 2015
Adjuvant chemotherapy for resected early-stage non-small cell lung cancerSarah Burdett, Jean Pierre Pignon, Jayne Tierney, et al.
The Lancet. Oncology|June 17, 2020
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort studyMarina Chiara Garassino, Jennifer G Whisenant, Li-Ching Huang, et al.
Biomedicine Hub|February 10, 2021
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in OncologyDenis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Lancet. Respiratory Medicine|May 20, 2019
Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trialGiorgio V Scagliotti, Rabab Gaafar, Anna K Nowak, et al.
Eclinicalmedicine|April 9, 2025
Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation studyLuigi Lim, Abigirl Machingura, Mekdes Taye, et al.
Cell Reports. Medicine|November 9, 2023
Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort BXiuning Le, Luis G Paz-Ares, Jan Van Meerbeeck, et al.
Cancers|February 5, 2021
Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised MedicineDenis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
The European Respiratory Journal|October 6, 2023
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancerEmma L O'Dowd, Ilona Tietzova, Emily Bartlett, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 7, 2023
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancerEmma L O'Dowd, Ilona Tietzova, Emily Bartlett, et al.
The New England Journal of Medicine|May 30, 2020
Tepotinib in Non-Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping MutationsPaul K Paik, Enriqueta Felip, Remi Veillon, et al.
The Cochrane Database of Systematic Reviews|March 3, 2015
Adjuvant chemotherapy for resected early-stage non-small cell lung cancerSarah Burdett, Jean Pierre Pignon, Jayne Tierney, et al.
The Lancet. Oncology|June 17, 2020
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort studyMarina Chiara Garassino, Jennifer G Whisenant, Li-Ching Huang, et al.
Biomedicine Hub|February 10, 2021
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in OncologyDenis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
Pageof 6